Clinical efficacy of buprenorphine: comparisons to methadone and placebo.
about
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependencePharmacological therapies for maintenance treatments of opium dependenceThe effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.Neonatal abstinence syndrome after methadone or buprenorphine exposureA multi-site, two-phase, Prescription Opioid Addiction Treatment Study (POATS): rationale, design, and methodologyConducting clinical research with prescription opioid dependence: defining the population.Partnerships and pathways of dissemination: the National Institute on Drug Abuse-Substance Abuse and Mental Health Services Administration Blending Initiative in the Clinical Trials Network.Provision of ancillary medications during buprenorphine detoxification does not improve treatment outcomesHIV/AIDS and drug use in China--interactions, impacts, and issues.Health-related quality of life changes associated with buprenorphine treatment for opioid dependence.Buprenorphine: a (relatively) new treatment for opioid dependence.Buprenorphine pharmacotherapy and behavioral treatment: comparison of outcomes among prescription opioid users, heroin users and combination usersPharmacological enhancement of naltrexone treatment for opioid dependence: a reviewImplementing buprenorphine in addiction treatment: payer and provider perspectives in Ohio.Participant characteristics and buprenorphine dose.The Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level AnalysisA multisite pilot study of extended-release injectable naltrexone treatment for previously opioid-dependent parolees and probationers.Bridging waitlist delays with interim buprenorphine treatment: initial feasibility.Sublingual buprenorphine/naloxone precipitated withdrawal in subjects maintained on 100mg of daily methadone.Abuse liability of intravenous buprenorphine/naloxone and buprenorphine alone in buprenorphine-maintained intravenous heroin abusersInnovation adoption in substance abuse treatment: exposure, trialability, and the Clinical Trials Network.Opioid maintenance: a comparative review of pharmacological strategies.Craving predicts opioid use in opioid-dependent patients initiating buprenorphine treatment: a longitudinal study.Counselor training and attitudes toward pharmacotherapies for opioid use disorder.Use of an Acetyl Derivative to Improve GC-MS Determination of Norbuprenorphine in the Presence of High Concentrations of Buprenorphine in Urine.The role of human drug self-administration procedures in the development of medications.Selective review and commentary on emerging pharmacotherapies for opioid addiction.Comparison of behavioral treatment conditions in buprenorphine maintenance.Heroin anticraving medications: a systematic review.A case series of buprenorphine/naloxone treatment in a primary care practice.Factors associated with non-adherence to Buprenorphine-naloxone among opioid dependent African-Americans: A retrospective chart review.Medication-assisted treatment for substance use disorders within a national community health center research network.Buprenorphine in the treatment of opiate dependence.Is methadone too dangerous for opiate addiction? Methadone is still needed in addiction treatments.Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.The effects of Buprenorphine/Naloxane Maintenance Treatment on the Quality of Life, Substance Use and Functionality in Opiate Dependence: A Follow-Up Study
P2860
Q24200539-4D13DA04-66DA-4594-A0DE-DD7DD4991960Q24201615-BDF5553B-F03E-44FB-A5E9-D96F717B13A9Q30490602-8438FDCA-0237-4573-8F7B-4B27E2208F99Q30499416-FF69CDF1-3D55-4B03-AE64-DB6635F2C396Q33699066-3BEC2ABF-9EE0-4537-BA0C-CD81BAB68168Q33779302-AB5629DD-E447-4370-A86D-F32840148084Q33793165-92DFA7A5-2F92-4E8F-92EA-02EB45E9733FQ33795318-36622698-3A3A-4C55-B1AB-68C216E90C64Q34119447-1315B6BF-B129-4947-8165-B74DB8B27296Q34129263-AFFA3E47-74E2-416F-B6AF-79412AE37319Q34365302-BA3D5FB6-80F3-4453-B130-76C5C2A4EC5DQ34602600-4C9CF9BB-E914-40D3-975C-2E93198B3978Q35084340-1B0D23FD-41DE-4FFB-944B-C997E6371868Q35400440-231C62A2-3676-47E5-86F5-BAC59E532999Q35738688-7EF86B32-D902-44C9-BA8C-78D1F3B423A2Q35828982-D27ABF1D-C2D3-4589-A68E-39F6C0AD0770Q36003432-930FD035-26B3-4B67-8845-B1F63F2AE2DDQ36021346-BB0B2D07-E772-4845-BD4E-456CD15C92B5Q36170053-0DE40F75-EFE4-44CA-A811-D45567F3D3A9Q36372149-95E5E213-981D-4E90-8866-284286BFD74DQ36627877-B54AE4C7-C705-4EC9-BC9F-194D9062AB85Q36681297-E3D90DA3-7228-496B-B5FD-50F061EC7243Q36904668-09065BD9-D948-4AA0-AE5D-45EE0C620BF2Q36934945-C603DFF2-4191-4D8B-A032-955DFCCDA344Q36948818-CF4796BA-A128-4BDE-A8E5-07E2F78FB7ACQ37147515-6145C1B6-C8DB-46CF-B28B-D85F9F82DCD9Q37355286-FCD0DBC8-877C-4F4F-A5E2-8A54F7A9FBB0Q37400852-BD97E1CB-3532-4E52-A925-65B5258FDF6EQ37800930-032990DD-00F5-4E9B-B77A-2F5430FAB32FQ37947698-09FD9D13-8601-4CE1-9533-3A5EB3F19E8CQ38691415-C4CF0CE5-DE50-4422-9A7C-D0DAF0024407Q39740604-946C5013-67B7-467A-8F43-9DF971789FACQ42962930-EE010521-D49A-458E-B7F0-4E0B8B9BB8B5Q43152213-F8D7B0D1-232C-430B-B1D4-23E8B3B5E018Q46416517-10939B8E-9D0D-43B8-90D8-ADEF236004E9Q58826486-D64E62AF-016D-4D69-AAB7-0C3653061F08
P2860
Clinical efficacy of buprenorphine: comparisons to methadone and placebo.
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Clinical efficacy of buprenorphine: comparisons to methadone and placebo.
@ast
Clinical efficacy of buprenorphine: comparisons to methadone and placebo.
@en
type
label
Clinical efficacy of buprenorphine: comparisons to methadone and placebo.
@ast
Clinical efficacy of buprenorphine: comparisons to methadone and placebo.
@en
prefLabel
Clinical efficacy of buprenorphine: comparisons to methadone and placebo.
@ast
Clinical efficacy of buprenorphine: comparisons to methadone and placebo.
@en
P1476
Clinical efficacy of buprenorphine: comparisons to methadone and placebo.
@en
P2093
Donald R Wesson
Walter Ling
P304
P356
10.1016/S0376-8716(03)00059-0
P433
P577
2003-05-01T00:00:00Z